Monaco, March 29, 2025 — Global biotech
company Dexlevo successfully wrapped up a three-day Aesthetic & Anti-Aging
Medicine World Congress (AMWC) 2025 in Monaco, drawing significant
international attention with its showcase of GOURI, the world’s first liquid
polycaprolactone (PCL) injectable.
During the AMWC, Dexlevo held three
symposiums from March 27 to 29, which brought together renowned medical
professionals from around the world to explore the clinical innovations and
efficacy of GOURI, a next-generation collagen biostimulator that is redefining
the aesthetic medicine landscape.
The first symposium opened with a keynote
presentation by Dr. Akaluck Thammasunthorn from Thailand, titled “The
Possibilities of Liquid PCL GOURI: A Flexible and Powerful Anti-Aging
Solution.” His in-depth lecture explored the unique advantages of liquid PCL in
facial aesthetics and featured a live demonstration focusing on forehead
application that received enthusiastic applause from attendees. One
practitioner noted, “The live demo clearly showed how easy GOURI’s application
is and how different it from any other conventional biostimulator. It was an
inspiring way to open the first day of congress.”
Dr. Olaf Young Fleischer from Germany
continued the second-day clinical session with lecture on his clinical
experiences and data-driven injection dosing strategies. Dr. Fleischer’s
session resonated strongly with attendees. A European dermatologist commented,
“His session offered valuable, practical insights I can apply in my clinic
immediately.”
Right after that Dr. Emmanouil Dimonitsas
from Greece delivered a highly engaging presentation on the use of liquid PCL
biostimulator GOURI in treating challenging areas and various dermatological
conditions. In his lecture, Dr. Dimonitsas discussed the unique advantages of
GOURI, emphasizing its role of the treatment in improving patients' quality of
life. His presentation not only showcased advanced techniques but also
reflected a deep understanding of aesthetic dermatology, earning him resounding
applause and recognition from the audience.
The last day symposium included Dr.
Senhime Akashi's presentation from Japan which expanded the conversation beyond
facial treatments with the topic of hand rejuvenation. Her talk explored the
potential of liquid PCL for body-focused regenerative treatments, sparking wide
interest among medical professionals seeking holistic anti-aging solutions.
One attendee shared, “Dr. Akashi’s
presentation opened new possibilities in body rejuvenation therapies using
liquid PCL.”
Dr. Mathelda Weni from Indonesia explored
the role of liquid polycaprolactone as a product that enhances skin firmness
and promotes natural lifting effects. She explained how liquid PCL works by
stimulating collagen production over time, offering a non-surgical solution for
patients seeking long-term skin rejuvenation.
Throughout the conference, Dexlevo’s
exhibition booth became a dynamic hub for global networking, attracting medical
professionals, academic leaders, and business partners from across the world.
Visitors engaged with Dexlevo’s medical research team, observed live
demonstrations from the symposium, and gained insight into the company’s
international expansion strategy.
As awareness grows globally around
GOURI’s safety, efficacy, and versatility, the product is gaining strong
traction in overseas markets. With its foundation in the principles of Korean
beauty, Dexlevo is quickly emerging as a leading brand in the global aesthetic
medicine industry.